Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Mediaco Holding Inc.MDIA · Entity 6814 | 10% owner | May 01, 2025 | May 05, 2025 |
| Rein Therapeutics, Inc.ALRN · Entity 7071 | Director · 10% owner | July 05, 2017 | August 14, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Mediaco Holding Inc.
Report date May 01, 2025 · Filed May 05, 2025
Jointly reported with HPS Group GP, LLC, SLF LBI Aggregator, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 7,051,538 |
Reported balance
After 2025-05-01 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-05-01 · Exercise / conversion · Acquired 7,051,538 · Balance 7,051,538 F1: On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC ("Aggregator"), including Estrella Media, Inc. ("Estrella Media"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the "Option Transaction"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock. F2: HPS Group GP, LLC ("HPS Group") is the non-member manager of Aggregator. Scott Kapnick is the sole member of HPS Group. F3: On March 19, 2025, Estrella Media filed an Initial Statement of Beneficial Ownership to add Estrella Media as a reporting person with respect to the Put Right. This Form 4 reflects withdrawal of Estrella Media as a reporting person. |
| OptionSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2025-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-01 · Exercise / conversion · Disposed 7,051,538 · Balance 0 F1: On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC ("Aggregator"), including Estrella Media, Inc. ("Estrella Media"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the "Option Transaction"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock. F2: HPS Group GP, LLC ("HPS Group") is the non-member manager of Aggregator. Scott Kapnick is the sole member of HPS Group. F3: On March 19, 2025, Estrella Media filed an Initial Statement of Beneficial Ownership to add Estrella Media as a reporting person with respect to the Put Right. This Form 4 reflects withdrawal of Estrella Media as a reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC ("Aggregator"), including Estrella Media, Inc. ("Estrella Media"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the "Option Transaction"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock.
F2: HPS Group GP, LLC ("HPS Group") is the non-member manager of Aggregator. Scott Kapnick is the sole member of HPS Group.
F3: On March 19, 2025, Estrella Media filed an Initial Statement of Beneficial Ownership to add Estrella Media as a reporting person with respect to the Put Right. This Form 4 reflects withdrawal of Estrella Media as a reporting person.
Rein Therapeutics, Inc.
Report date July 05, 2017 · Filed August 14, 2018 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 66,666 |
Reported balance
After 2017-07-05 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2017-07-05 · Purchase · Acquired 66,666 · Balance 66,666 F1: The amount of securities previously reported as beneficially owned by the Reporting Person inadvertently aggregated shares that the Reporting Person indirectly beneficially owned with shares that the Reporting Person directly beneficially owned following the transaction reported on the original Form 4. The correct number of shares that the Reporting Person indirectly beneficially owned following this transaction was 66,666 shares. F2: These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The amount of securities previously reported as beneficially owned by the Reporting Person inadvertently aggregated shares that the Reporting Person indirectly beneficially owned with shares that the Reporting Person directly beneficially owned following the transaction reported on the original Form 4. The correct number of shares that the Reporting Person indirectly beneficially owned following this transaction was 66,666 shares.
F2: These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2025 Filed May 5, 2025 18:12 UTC | Mediaco Holding Inc. MDIA · Entity 6814 | Exercise / conversionOption · Derivative | 7,051,538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-25-001254 · es250623799_4-mdia.xml · derivative · entry 2 HPS Group GP, LLC · CIK 0002019987 · 10% owner Kapnick Scott · CIK 0001709654 · 10% owner SLF LBI Aggregator, LLC · CIK 0002020124 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 7,051,538 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC ("Aggregator"), including Estrella Media, Inc. ("Estrella Media"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the "Option Transaction"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock. F1 · price: On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC ("Aggregator"), including Estrella Media, Inc. ("Estrella Media"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the "Option Transaction"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock. F1 · derivative.exercise_date: On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC ("Aggregator"), including Estrella Media, Inc. ("Estrella Media"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the "Option Transaction"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock. F1 · derivative.expiration_date: On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC ("Aggregator"), including Estrella Media, Inc. ("Estrella Media"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the "Option Transaction"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock. F2 · ownership.nature: HPS Group GP, LLC ("HPS Group") is the non-member manager of Aggregator. Scott Kapnick is the sole member of HPS Group. F3 · ownership.nature: On March 19, 2025, Estrella Media filed an Initial Statement of Beneficial Ownership to add Estrella Media as a reporting person with respect to the Put Right. This Form 4 reflects withdrawal of Estrella Media as a reporting person. Read SEC document |
| May 01, 2025 Filed May 5, 2025 18:12 UTC | Mediaco Holding Inc. MDIA · Entity 6814 | Exercise / conversionClass A Common Stock | 7,051,538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-25-001254 · es250623799_4-mdia.xml · nonDerivative · entry 1 HPS Group GP, LLC · CIK 0002019987 · 10% owner Kapnick Scott · CIK 0001709654 · 10% owner SLF LBI Aggregator, LLC · CIK 0002020124 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,051,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC ("Aggregator"), including Estrella Media, Inc. ("Estrella Media"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the "Option Transaction"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock. F2 · ownership.nature: HPS Group GP, LLC ("HPS Group") is the non-member manager of Aggregator. Scott Kapnick is the sole member of HPS Group. F3 · ownership.nature: On March 19, 2025, Estrella Media filed an Initial Statement of Beneficial Ownership to add Estrella Media as a reporting person with respect to the Put Right. This Form 4 reflects withdrawal of Estrella Media as a reporting person. Read SEC document |
| July 25, 2017 Filed Jul 27, 2017 22:29 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000899243-17-019212 · doc4.xml · derivative · entry 1 Kapnick Scott · CIK 0001709654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-07-24 F1 · derivative.exercise_date: This option was granted on July 25, 2017. The shares underlying the option are scheduled to vest in equal annual installments over three years from July 25, 2017. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 00:25 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries F Preferred Stock · Derivative | 487,776 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-017894 · doc4.xml · derivative · entry 8 Kapnick Scott · CIK 0001709654 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,086 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 00:25 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries E-3 Preferred Stock · Derivative | 1,266,130 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-017894 · doc4.xml · derivative · entry 7 Kapnick Scott · CIK 0001709654 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 127,415 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 00:25 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries E-2 Preferred Stock · Derivative | 612,002 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-017894 · doc4.xml · derivative · entry 6 Kapnick Scott · CIK 0001709654 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,588 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 00:25 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries D-1 Preferred Stock · Derivative | 363,636 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-017894 · doc4.xml · derivative · entry 5 Kapnick Scott · CIK 0001709654 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 00:25 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries D Preferred Stock · Derivative | 106,856 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-017894 · doc4.xml · derivative · entry 4 Kapnick Scott · CIK 0001709654 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,753 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 00:25 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | PurchaseCommon Stock | 66,666 | $15.00 | $999,990.00 |
DisclosureSEC source: 0000899243-17-017894 · doc4.xml · nonDerivative · entry 3 Kapnick Scott · CIK 0001709654 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 521,049 F2 · ownership.nature: These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 00:25 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | PurchaseCommon Stock | 159,307 | $15.00 | $2,389,605.00 |
DisclosureSEC source: 0000899243-17-017894 · doc4.xml · nonDerivative · entry 2 Kapnick Scott · CIK 0001709654 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,383 Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 00:25 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionCommon Stock | 285,438 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-017894 · doc4.xml · nonDerivative · entry 1 Kapnick Scott · CIK 0001709654 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| July 05, 2017 Filed Aug 14, 2018 20:35 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | PurchaseCommon Stock | 66,666 | $15.00 | $999,990.00 |
DisclosureSEC source: 0000899243-18-022295 · doc4a.xml · nonDerivative · entry 1 Kapnick Scott · CIK 0001709654 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 66,666 F1 · balance_after: The amount of securities previously reported as beneficially owned by the Reporting Person inadvertently aggregated shares that the Reporting Person indirectly beneficially owned with shares that the Reporting Person directly beneficially owned following the transaction reported on the original Form 4. The correct number of shares that the Reporting Person indirectly beneficially owned following this transaction was 66,666 shares. F2 · ownership.nature: These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.